Creutzfeldt‐Jakob disease with neuroleptic malignant syndrome

Čiauškaitė, Julija; Puleikytė, Ieva; Jesmanas, Simonas; Jurkevičienė, Giedrė; Vaitkus, Antanas; Rastenytė, Daiva

doi:10.1002/ccr3.4699

Cited by 3 publications

(1 citation statement)

References 28 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…We performed a review of NMS case reports from clinicians other than psychiatrists in English and Japanese literature. They could be classified into two groups: (1) cases in which NMS onset was triggered by administering causative drugs 17–19,22–89 and (2) cases in which NMS developed from disruption of regular medication (Tables 7 and 8). 8,16,90–114 An example of the former is a case in which antipsychotic drugs were administered for postoperative delirium; an example of the latter is a case in which regular medication (i.e., antipsychotic drugs) to treat schizophrenia was discontinued temporarily because of general anesthesia.…”

Section: Occurrences Of Nms In Fields Other Than Psychiatrymentioning

confidence: 99%

Neuroleptic malignant syndrome in fields other than psychiatry

Shimada

Kase

Nakatsuru

et al. 2023

Oral Science International

View full text Add to dashboard Cite

Neuroleptic malignant syndrome (NMS) is an adverse effect of drugs, mainly neuroleptics. It is characterized by problems related to the autonomic nervous system (such as hyperthermia, diaphoresis, and tachycardia) and extrapyramidal symptoms (such as muscle rigidity and tremor). After onset, NMS progresses rapidly and without treatment, becomes life‐threatening. In recent years, NMS has become better recognized, and treatment has improved; most cases are now curable before becoming dangerous. Most NMS reports are from psychiatrists or neurologists; few are from other specialized clinicians. However, nonpsychiatric clinicians, such as surgeons, emergency physicians, orthopedists, and oral surgeons, sometimes must administer neuroleptic drugs. Although NMS is rare, its effects on patients may be debilitating, and this places a heavy burden on clinicians. Thus, not only psychiatrists but also clinicians in various other fields should understand this illness. This article describes NMS in fields other than psychiatry and its diagnosis, risk factors, and treatment strategies.

show abstract

Section: Occurrences Of Nms In Fields Other Than Psychiatrymentioning

confidence: 99%

Neuroleptic malignant syndrome in fields other than psychiatry

Shimada

Kase

Nakatsuru

et al. 2023

Oral Science International

View full text Add to dashboard Cite

show abstract

Lorazepam/quetiapine

2022

Reactions Weekly

View full text Add to dashboard Cite

Kreytsfeld-Yakob Xəstəli̇yi̇ni̇n Di̇aqnosti̇kasinin Çəti̇nli̇kləri̇ (Prakti̇k Müşahi̇də)

Коленко,

Потапов,

Юрченко

et al. 2023

Azerbaijan Medical Journal

View full text Add to dashboard Cite

Болезнь Крейтцфельдта-Якоба (БКЯ) или трансмиссивная губчатая энцефалопатия – заболевание нервной системы из группы редких прионовых нейродегенеративных заболеваний. Накопление патологической формы специфического белка PrPSc приводит к гибели нервных клеток. Эти факты, а также особенности эпидемиологии, отсутствие специфических клинических признаков обуславливают ряд сложностей прижизненной диагностики этой болезни. В данной статье приведен случай вероятной БКЯ у пациентки неврологического отделения для больных с нарушениями мозгового кровообращения. Рассмотрен один из возможных ее фенотипических вариантов. Уделено внимание трудностям постановки диагноза. Kleytsfeld-Yakob xəstəliyi (KYX) və ya transmissiv süngərşəkilli ensefalopatiya sinir sisteminin prion tipli zülalların təsirindən törənən nadir degenerativ xəstəliyidir. Xəstəlik zamanı PrPSe qrupundan olan spesifik formalı züllaların toplanması nəticəsində sinir hüceyrələrinin ölümü baş verir. Bu fakt, xəstəliyin epidemiologiyasının xüsusiyyətləri və spesifik klinik əlamətlərinin olmaması adı çəkilən xəstəliyin diaqnostikasında müxtəlif çətinliklərin mövcudluğuna əsas verir. Təqdim edilən məqalədə nevroloji şöbədə beyin qan dövranının pozulmasına görə müalicə alan xəstədə KYX olduğuna şübhə yaranan xəstə haqqında məlumat verilmişdir; xəstəliyin fenotipik variantlarından biri nəzərdən keçirilmiş və diaqnostikanın çətinliyinə diqqət cəlb edilmişdir. Creutzfeldt-Jakob disease (CJD) or transmissible spongiform encephalopathy is a nervous system disease from the group of rare prion neurodegenerative diseases. Accumulation of the pathological form of the specific PrPSc protein leads to the death of nerve cells. These facts, as well as the peculiarities of epidemiology, the absence of specific clinical signs, cause a number of difficulties in the life-time diagnosis of this disease. This article presents a case of probable CJD in a patient of the neurological department for patients with cerebrovascular accidents. One of its possible phenotypic variants is considered. Attention is paid to the difficulties of making a diagnosis.

show abstract

Creutzfeldt‐Jakob disease with neuroleptic malignant syndrome

Cited by 3 publications

References 28 publications

Neuroleptic malignant syndrome in fields other than psychiatry

Neuroleptic malignant syndrome in fields other than psychiatry

Lorazepam/quetiapine

Kreytsfeld-Yakob Xəstəli̇yi̇ni̇n Di̇aqnosti̇kasinin Çəti̇nli̇kləri̇ (Prakti̇k Müşahi̇də)

Contact Info

Product

Resources

About